Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, γ-IFN and IL-4) in vitro
- 31 October 2001
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 9 (1), 1-6
- https://doi.org/10.1016/s0966-3274(01)00042-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IS ASSOCIATED WITH REDUCED Th1 CYTOKINE RESPONSES IN THE WKY???F344 RAT MODELTransplantation, 1999
- Influence of Antithrombin III on Coagulation and Inflammation in Porcine Septic ShockArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- ANTITHROMBIN III TREATMENT IMPROVES PARAMETERS OF ACUTE INFLAMMATION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT LUNG ALLOGRAFT REJECTIONTransplantation, 1999
- The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Antithrombin III Prevents and Rapidly Reverses Leukocyte Recruitment in Ischemia/ReperfusionCirculation, 1997
- Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCRTransplant Immunology, 1995
- Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulinTransplant Immunology, 1994
- Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulinJournal of Clinical Immunology, 1994
- Double-blind, Placebo-controlled Trial of Antithrombin III Concentrates in Septic Shock With Disseminated Intravascular CoagulationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1993
- THE ENDOTHELIAL HEPARAN SULFATE-ANTITHROMBIN III NATURAL ANTICOAGULANT PATHWAY IN NORMAL AND TRANSPLANTED HUMAN KIDNEYSTransplantation, 1992